EFIKAS
ActiveSummary
EFIKAS has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€99,125) and a net result of -€105,967. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 2372 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability0▼-7
Solvency8▼-18
Growth52=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity ample (current ratio 1.84 against 1.18 in 2024; short-term debt: 19.7% and cash: 16.4% of total assets), but equity is negative.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
-16.6%
Return on assets
-17.7%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year -€99,125
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-08-2026, 4 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
4 d late
2024
25 d late
2023
51 d late
2022
122 d late
2021
145 d late
2020
5 d early
2019
49 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 56 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 21 September (4 of the last 5 filed years within 70 days of that day).
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€105,967▼ 9.6%
2024 · -€96,703
Working capital
€98,501▲ 146%
2024 · €40,051
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€159,529▼ 45.3%€78,322▼ 50.9%€125,159▲ 59.8%-€65,727-€93,121▼ 41.7%
Net result€125,034within the sector's middle half▼ 41.1%€12,792within the sector's middle half▼ 89.8%€71,770within the sector's middle half▲ 461%-€96,703below the sector's middle half-€105,967below the sector's middle half▼ 9.6%
Equity€18,982below the sector's middle half▼ 13.5%€31,775below the sector's middle half▲ 67.4%€103,545within the sector's middle half▲ 226%€6,842below the sector's middle half▼ 93.4%-€99,125below the sector's middle half
Total assets€1.9mabove the sector's middle half▲ 96.5%€961,597within the sector's middle half▼ 48.9%€877,288within the sector's middle half▼ 8.8%€695,573within the sector's middle half▼ 20.7%€597,212within the sector's middle half▼ 14.1%
Debt€1.7m▲ 116%€792,007▼ 54.1%€773,743▼ 2.3%€688,731▼ 11.0%€696,337▲ 1.1%
Working capital€177,669within the sector's middle half▲ 17.1%€61,030within the sector's middle half▼ 65.6%€3,989below the sector's middle half▼ 93.5%€40,051within the sector's middle half▲ 904%€98,501within the sector's middle half▲ 146%
Solvency1.0%below the sector's middle half▼ 1.3pp3.3%below the sector's middle half▲ 2.3pp11.8%below the sector's middle half▲ 8.5pp1.0%below the sector's middle half▼ 10.8pp-16.6%below the sector's middle half▼ 17.6pp
Current ratio1.14below the sector's middle half▼ 0.251.17within the sector's middle half▲ 0.031.01below the sector's middle half▼ 0.161.18within the sector's middle half▲ 0.171.84within the sector's middle half▲ 0.65
Return on assets (ROA)6.6%within the sector's middle half▼ 15.5pp1.3%below the sector's middle half▼ 5.3pp8.2%within the sector's middle half▲ 6.9pp-13.9%below the sector's middle half▼ 22.1pp-17.7%below the sector's middle half▼ 3.8pp
Staff (FTE)4within the sector's middle half▲ 8.1%5.2within the sector's middle half▲ 30.0%5.7within the sector's middle half▲ 9.6%5within the sector's middle half▼ 12.3%4.9within the sector's middle half▼ 2.0%
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €93,121 in 2025 against €65,727 in 2024; the loss grows and 2025 has the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €597,212
Fixed assets
€380,764 ▼ 12.8%
Current assets
€216,448 ▼ 16.3%
Key figures and ratios
EBITDA
-€19,781▼
2024 · €11,398
Cash flow
-€32,627▼
2024 · -€19,578
Debt to equity
-7.02
Interest coverage
-1.32▼
2024 · 0.64
Debt ≤ 1 year
€117,947▼
2024 · €218,685
Debt > 1 year
€239,424▼
2024 · €299,195
Income taxes
-€4
Staff costs
€193,526▼
2024 · €204,173
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 6,940 companies that looked in July 2024 the way this one looks now, 5.5% went bankrupt within 24 months and 85% are still going.
- Micro
- 10 to 20 years old
- negative equity
- a loss of 10% of the balance sheet or more
5.5%
went bankrupt
8.0%
stopped otherwise
85%
still going
A further 1.5% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,940 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | €342,459 | - | - | - |
| Remuneration, social security and pensions62 | €213,264 | €263,428 | €253,346 | €204,173 | €193,526 | ▼ 5.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €56,980 | €65,612 | €79,619 | €77,125 | €73,340 | ▼ 4.9% |
| Other operating charges640/8 | €6,881 | €6,383 | €7,302 | €7,352 | €7,545 | ▲ 2.6% |
| Non-recurring operating charges66A | - | - | €217,253 | - | - | - |
| Gross operating margin9900 | €436,654 | €413,745 | €682,679 | €222,923 | €181,290 | ▼ 18.7% |
| Operating profit (loss)9901 | €159,529 | €78,322 | €125,159 | -€65,727 | -€93,121 | ▼ 41.7% |
| Financial income75/76B | €22,750 | €3,630 | €4,478 | €3,519 | €2,186 | ▼ 37.9% |
| Recurring financial income75 | €22,750 | €3,630 | €4,478 | €3,519 | €2,186 | ▼ 37.9% |
| Financial charges65/66B | €26,791 | €59,128 | €26,060 | €34,495 | €15,036 | ▼ 56.4% |
| Recurring financial charges65 | €26,791 | €59,128 | €26,060 | €17,842 | €15,036 | ▼ 15.7% |
| Non-recurring financial charges66B | - | - | - | €16,653 | - | - |
| Profit (loss) for the period before taxes9903 | €155,488 | €22,824 | €103,577 | -€96,703 | -€105,971 | ▼ 9.6% |
| Income taxes67/77 | €30,454 | €10,032 | €31,807 | - | -€4 | - |
| Profit (loss) for the period9904 | €125,034 | €12,792 | €71,770 | -€96,703 | -€105,967 | ▼ 9.6% |
| Profit (loss) for the period to be appropriated9905 | €125,034 | €12,792 | €71,770 | -€96,703 | -€105,967 | ▼ 9.6% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.9m | €961,597 | €877,288 | €695,573 | €597,212 | ▼ 14.1% |
| Fixed assets21/28 | €474,441 | €547,857 | €513,962 | €436,837 | €380,764 | ▼ 12.8% |
| Tangible fixed assets22/27 | €472,753 | €547,857 | €513,962 | €436,837 | €380,764 | ▼ 12.8% |
| Land and buildings22 | €432,733 | €304,836 | €272,306 | €239,777 | €207,247 | ▼ 13.6% |
| Plant, machinery and equipment23 | €24,939 | €215,530 | €210,359 | €180,835 | €166,761 | ▼ 7.8% |
| Furniture and vehicles24 | €15,082 | €27,491 | €31,297 | €16,225 | €6,756 | ▼ 58.4% |
| Financial fixed assets28 | €1,688 | - | - | - | - | - |
| Current assets29/58 | €1.4m | €413,741 | €363,326 | €258,736 | €216,448 | ▼ 16.3% |
| Amounts receivable after more than one year29 | €9,600 | - | - | - | - | - |
| Other amounts receivable291 | €9,600 | - | - | - | - | - |
| Amounts receivable within one year40/41 | €74,991 | €97,682 | €143,721 | €125,233 | €110,103 | ▼ 12.1% |
| Trade receivables40 | €52,948 | €72,825 | €96,222 | €86,039 | €88,625 | ▲ 3.0% |
| Other amounts receivable41 | €22,043 | €24,858 | €47,499 | €39,194 | €21,478 | ▼ 45.2% |
| Current investments50/53 | €234,449 | €230,917 | €122,000 | €124,000 | €7,000 | ▼ 94.4% |
| Cash at bank and in hand54/58 | €1.1m | €84,704 | €91,910 | €3,862 | €98,137 | ▲ 2,441% |
| Deferred charges and accrued income490/1 | - | €437 | €5,695 | €5,641 | €1,208 | ▼ 78.6% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.9m | €961,597 | €877,288 | €695,573 | €597,212 | ▼ 14.1% |
| Equity10/15 | €18,982 | €31,775 | €103,545 | €6,842 | -€99,125 | ▼ 1,549% |
| Contributions10/11 | €18,600 | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Profit (loss) carried forward14 | €382 | €13,175 | €84,945 | -€11,758 | -€117,725 | ▼ 901% |
| Provisions and deferred taxes16 | €137,816 | €137,816 | - | - | - | - |
| Provisions for liabilities and charges160/5 | €137,816 | €137,816 | - | - | - | - |
| Environmental obligations163 | €137,816 | - | - | - | - | - |
| Other liabilities and charges164/5 | - | €137,816 | - | - | - | - |
| Amounts payable17/49 | €1.7m | €792,007 | €773,743 | €688,731 | €696,337 | ▲ 1.1% |
| Amounts payable after more than one year17 | €493,608 | €439,296 | €370,237 | €299,195 | €239,424 | ▼ 20.0% |
| Financial debts170/4 | €493,608 | €439,296 | €370,237 | €299,195 | €239,424 | ▼ 20.0% |
| Amounts payable within one year42/48 | €1.2m | €352,711 | €359,337 | €218,685 | €117,947 | ▼ 46.1% |
| Current portion of amounts payable after more than one year42 | €68,141 | €73,978 | €75,879 | €77,857 | €66,581 | ▼ 14.5% |
| Financial debts43 | - | - | - | €40,270 | - | - |
| Credit institutions430/8 | - | - | - | €40,270 | - | - |
| Trade debts44 | €911,281 | €107,937 | €131,791 | €72,314 | €29,285 | ▼ 59.5% |
| Suppliers440/4 | €911,281 | €107,937 | €131,791 | €72,314 | €29,285 | ▼ 59.5% |
| Taxes, remuneration and social security45 | €121,725 | €67,796 | €48,667 | €28,244 | €22,081 | ▼ 21.8% |
| Taxes450/3 | €89,688 | €39,531 | €24,293 | €5,054 | €5,054 | = |
| Remuneration and social security454/9 | €32,037 | €28,265 | €24,374 | €23,190 | €17,027 | ▼ 26.6% |
| Other amounts payable47/48 | €128,000 | €103,000 | €103,000 | - | - | - |
| Accrued charges and deferred income492/3 | €1,704 | - | €44,169 | €170,851 | €338,966 | ▲ 98.4% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €125,034 | €12,792 | €71,770 | -€96,703 | -€105,967 | ▼ 9.6% |
| + Depreciation and write-downs630 | €56,980 | €65,612 | €79,619 | €77,125 | €73,340 | ▼ 4.9% |
| Operating cash flow (approximation) | €182,014 | €78,404 | €151,389 | -€19,578 | -€32,627 | ▼ 66.7% |
| Investment in fixed assets (approximation) | - | -€139,027 | -€45,725 | €0 | -€17,267 | - |
| Change in cash | - | -€1.0m | €7,206 | -€88,048 | €94,275 | ▲ 207% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
04-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 4 days late
2025
31-12
Financial
Weakest financial yearnet -€105,967
Net result drops to -€105,967, the lowest in the series.
25-08
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 25 days late
2024
20-09
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 51 days late
2023
31-12
Financial
Equity above €100,000Eq €103,545 ▲226%
5 profitable years in a row build equity to €103,545.
30-11
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 122 days late
2022
23-12
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 145 days late
2021
26-07
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
31-12
Financial
Highest result since 2018net €212,261 ▲111%
Operating result €291,842, net result €212,261, both a record.
18-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 49 days late
2019
31-12
Financial
Back to profitnet €100,814
Net result €100,814 after one loss-making year.
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 30 days late
2018
28-09
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 59 days late
2017
30-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Elsene · 1 establishment unit since 2010
Ground area
1,401 m²
Building footprint
786 m²
Volume, LiDAR
12,470 m³
Parcel 21446D0061/00Z000, Brussels · tallest building 20.0 m, ±5 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
Centre DDG
since 20102.231.866.466
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21446D0061/00Z000 | Brussels | 1,401 m² | 1 · 786 m² | 19.9 m · 5 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
3 ownersOwners 3
-
50%
- ARTHUR GILLARDnatural personSourceown accounts 202525%
- MICHEL FIASSEnatural personSourceown accounts 202525%
Holdings 0
The accounts to 31-12-2025 list no holdings, and no other source names one.
According to the 2025 annual accounts of EFIKAS and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Recognitions · licences · registrations
Legal Entity Identifier
699400J1SU3AP6OHHK83
Similar companies · same sector, comparable size
Dr. Pattyn Thomas - Psychiater
BE 0735.407.874
Bonheiden · Eq €6,845
CharlauRAD
BE 0741.848.872
Roeselare · Eq €6,870
MCR Operations
BE 0786.976.638
Rotselaar · Eq €6,887
Dr. Brands Michiel
BE 0771.461.487
Hasselt · Eq €6,797
Dr. Zemtsova Olena, Gynaecologie
BE 0759.867.019
Hemiksem · Eq €6,896
Of 16,629 companies in sector 86220 we hold annual accounts for 7,986. 1,727 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded23-11-2010
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0831299797
Also
9925:BE0831299797
Registered
07-01-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.